BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29296746)

  • 1. Genetic variants in
    Ma Q; Jacobi PM; Emmer BT; Kretz CA; Ozel AB; McGee B; Kimchi-Sarfaty C; Ginsburg D; Li JZ; Desch KC
    Blood Adv; 2017 Jun; 1(15):1037-1046. PubMed ID: 29296746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare Variants in the ADAMTS13 Von Willebrand Factor-Binding Domain Contribute to Pediatric Stroke.
    Stoll M; Rühle F; Witten A; Barysenka A; Arning A; Strauss C; Nowak-Göttl U
    Circ Cardiovasc Genet; 2016 Aug; 9(4):357-67. PubMed ID: 27412500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association.
    Desch KC; Ozel AB; Siemieniak D; Kalish Y; Shavit JA; Thornburg CD; Sharathkumar AA; McHugh CP; Laurie CC; Crenshaw A; Mirel DB; Kim Y; Cropp CD; Molloy AM; Kirke PN; Bailey-Wilson JE; Wilson AF; Mills JL; Scott JM; Brody LC; Li JZ; Ginsburg D
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):588-93. PubMed ID: 23267103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
    Kokame K
    Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project.
    Souto JC; Almasy L; Soria JM; Buil A; Stone W; Lathrop M; Blangero J; Fontcuberta J
    Thromb Haemost; 2003 Mar; 89(3):468-74. PubMed ID: 12624629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
    Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
    Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
    Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
    Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.
    Kokame K; Matsumoto M; Soejima K; Yagi H; Ishizashi H; Funato M; Tamai H; Konno M; Kamide K; Kawano Y; Miyata T; Fujimura Y
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11902-7. PubMed ID: 12181489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shear stress and von Willebrand factor in health and disease.
    Tsai HM
    Semin Thromb Hemost; 2003 Oct; 29(5):479-88. PubMed ID: 14631548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment.
    Hori Y; Hayakawa M; Isonishi A; Soejima K; Matsumoto M; Fujimura Y
    Transfusion; 2013 Dec; 53(12):3192-202. PubMed ID: 23560518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy.
    Groeneveld DJ; Alkozai EM; Adelmeijer J; Porte RJ; Lisman T
    Br J Surg; 2016 May; 103(6):735-743. PubMed ID: 27005894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
    Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
    Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity.
    de Vries PS; Boender J; Sonneveld MA; Rivadeneira F; Ikram MA; Rottensteiner H; Hofman A; Uitterlinden AG; Leebeek FW; Franco OH; Dehghan A; de Maat MP
    Blood; 2015 Jun; 125(25):3949-55. PubMed ID: 25934476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor.
    Casonato A; Pontara E; Battiston M; Morpurgo M; Cattini MG; Casarin E; Saga G; Daidone V; De Marco L
    Thromb Haemost; 2013 Jun; 109(6):999-1006. PubMed ID: 23446343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease.
    Miura M; Kaikita K; Matsukawa M; Soejima K; Fuchigami S; Miyazaki Y; Ono T; Uemura T; Tsujita K; Hokimoto S; Sumida H; Sugiyama S; Matsui K; Yamabe H; Ogawa H
    Thromb Haemost; 2010 Mar; 103(3):623-9. PubMed ID: 20135067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation.
    Peyvandi F; Siboni SM; Lambertenghi Deliliers D; Lavoretano S; De Fazio N; Moroni B; Lambertenghi Deliliers G; Mannuccio Mannucci P
    Br J Haematol; 2006 Jul; 134(2):187-95. PubMed ID: 16846477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients.
    Bongers TN; de Bruijne EL; Dippel DW; de Jong AJ; Deckers JW; Poldermans D; de Maat MP; Leebeek FW
    Atherosclerosis; 2009 Nov; 207(1):250-4. PubMed ID: 19439298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension.
    van den Born BJ; van der Hoeven NV; Groot E; Lenting PJ; Meijers JC; Levi M; van Montfrans GA
    Hypertension; 2008 Apr; 51(4):862-6. PubMed ID: 18332284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.